The largest database of trusted experimental protocols

Anti myc 9e10

Manufactured by BioLegend

Anti-Myc (9E10) is a mouse monoclonal antibody that specifically recognizes the c-Myc protein. It can be used to detect and purify c-Myc fusion proteins in various applications.

Automatically generated - may contain errors

3 protocols using anti myc 9e10

1

Characterizing VLR Affinity for bEnd.3 ECM

Check if the same lab product or an alternative is used in the 5 most similar protocols
To characterize VLR affinity for bEnd.3 ECM, dilutions of purified VLR were incubated with ECM. P1C10 VLR was diluted using a sixfold dilution scheme from 10 μM to 0.21 nM and then incubated with bEnd.3 ECM. Wells were washed five times with PBS + 0.05% Tween 20 and then inubcated with anti-myc 9E10, 1:750, (BioLegend) and goat anti-mouse IgG modified with HRP. Wells were washed seven times with PBS + 0.05% Tween 20 and then incubated with TMB substrate. Reaction was stopped after 15 min by acidification with 1 M HCl. Absorbance at 450 nm was quantified, and data were fit to a one-site equilibrium binding model to determine Kd as previously described (43 (link)). The amino acid sequence for VLR P1C10 is ACPSQCSCDQTTVKCHSRRLTSVPAGIPTTTKILRLYSNQITKLEPGVFDHLVNLEKLYISWNQLSALPVGVFDKLTKLTHLSLGYNQLKSVPRGAFDNLKSLTHIWLLNNPWDCECSDILYLKNWIVQHASIVNLQGHGGVDNVKCSGTNTPVRAVTEASTSPSKCP.
+ Open protocol
+ Expand
2

CORO1A Construct Generation and Co-Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Myc- or FLAG-tagged wild-type (WT) human CORO1A construct by PCR amplification of human COROA1A cDNA (Open Biosystems, Pittsburgh, PA) using standard cloning techniques. Myc- or FLAG-tagged mutant CORO1A expression constructs were generated from the wild-type constructs by insertional mutagenesis with the QuikChange II system (Agilent, Santa Clara, CA). FLAG-PYK2 was generated as described.17 (link) 293T cells were co-transfected with specified combination of tagged CORO1A or PYK2 plasmids using Transit-LT1 (Mirus Bio, Madison, WI). After 48 hours, cells were lysed with 1% Triton-X100 buffer. Immunoprecipitation and immunoblotting were performed using a monoclonal anti-FLAG (M2, Sigma-Aldrich) or anti-Myc (9E10, BioLegend) antibody and Protein G agarose (Calbiochem, Temecula, CA).
+ Open protocol
+ Expand
3

In Vitro SUMOylation of Sgo1 and Rts1 Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified Sgo1 (1 µM) was mixed with 5 mM ATP, 15 µM SUMO, 0.5 µM E1 (unless otherwise indicated), 0.5 µM E2 (unless otherwise indicated), and 0.1 µM (unless otherwise indicated) Siz1 (167–508) or Siz2 in a reaction buffer consisting of 25 mM Hepes, pH 7.5, 150 mM KCl, 10 mM MgCl2, 15% glycerol, 0.1% NP-40, 0.1 mM DTT, and 0.25 mM PMSF. The reaction was incubated at 30°C for 2 h (unless otherwise indicated). For detection of SUMOylated Sgo1, the reaction was boiled in SDS sample buffer before analysis by anti-V5 Western blotting.
For Rts1 binding assay, the product of in vitro SUMOylation was incubated with anti-V5 (#MCA1360; Bio-Rad AbD Serotec)–coupled protein G magnetic Dynabeads (Thermo Fisher Scientific) in binding buffer A (25 mM Hepes, pH 7.5, 150 mM KCl, 2 mM MgCl2, 15% glycerol, 0.1% NP-40, 0.1 mM EDTA, 0.5 mM EGTA, and 0.25 mM PMSF) for 2.5 h at 4°C. After washing three times with binding buffer A, beads were incubated with extract from strain AMy8832 for 2 h at 4°C. Beads were washed five times with binding buffer A + 10 mM N-ethylmaleimide and were heated at 65°C for 15 min to elute bound proteins. Sgo1 binding assay was performed similarly, except that Rts1-9Myc was immunoprecipitated from lysate of strain AM8832 by anti-Myc (9E10, #626802; BioLegend)–coupled protein G Dynabeads and subsequently incubated with products of in vitro SUMOylation (with or without ATP).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!